Meta Pixel

News and Announcements

Invigor Quick to Secure the Wins of Sprooki Acquisition

  • Published May 09, 2017 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

Only a fortnight after Invigor Group (ASX: IVO) announced the pending acquisition of major shopper engagement, analytics and commerce platform, Sprooki, the company has reaped the rewards of this initiative.

KEY TAKEAWAYS:

  • The 120,000 square metre Plaza shopping centre located in Yogyakarta Indonesia will be the first to launch Sprooki’s award-winning mobile engagement solution.
    • The shopping centre is the premier shopping, dining and lifestyle destination in Yogyakarta with more than 230 exclusive local and international brand-name stores.
  • The mall recently launched a new shopping companion mobile application powered by Sprooki’s solution to improve and personalise the experience of patrons to assist retailers with better shopper engagement, conversion and loyalty.
  • There are now 18 malls contracted to Sprooki in Asia.

Discussing this development, IVO’S Chairman and Chief Executive, Gary Cohen said, “One of the attractions of the Sprooki business to Invigorwas the strength of its customer growth opportunities and its ability to expand its shopping centre footprint in Asia, and this contract is evidence that Sprooki is converting its tenders to new revenue generating, long-term contracts in Asia”.

Sprooki is aggressively pursuing other contracts in Indonesia, a country with a population of 260 million people and almost 330 million mobile connections, evidence that the broader Indonesian population are some of the most engaged mobile users in the world.

In discussions with FinFeed, Cohen said, “We currently have over $7 million of new qualified deals in the pipeline including 36 shopping malls, nine major brands and two major retailers”.

IVO expects to report on further revenue generating contracts shortly, including more from Sprooki in Australia, Asia and Europe. With a substantial number of deals in the pipeline it would appear that there could be share price catalysts on the horizon.

While IVO’s shares have increased 35% in less than a month, the company’s growth prospects needs to be viewed in a completely different light following the transformational acquisition of Sprooki.

Consequently, with the potential for exponential growth moving forward there is the possibility of further share price upside.

It should be noted that share trading patterns should not be used as the basis for an investment as they may or may not be replicated. Those considering this stock should seek independent financial advice.

Request Offer

Company Updates
The Biofilm Breakthrough: How An Australian BioTech Firm Is Tapping Indonesia’s $45,000-a-Kitchen Bottleneck

Australian sustainability and deep-tech firm Altair International Pty Ltd is commercialising plant-based clinical hygiene technology, targeting a prime operational bottleneck in Indonesia’s massive national free meals program. Every few years, an Australian deep-tech company emerges combining proprietary science with a transformational anchor contract, the kind of business that quietly creates an entirely new market category […]

Capital Insights
THE TAX CHANGED. NOW THE PRODUCT IS CHANGING TO MATCH.

Changes to the 50% capital gains tax discount are shifting Australian private capital away from growth and into high-yielding wrappers. Fund managers are actively redesigning products across private credit and property to capture the incoming capital rotation

Capital Insights
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula

Oncology specialists are still calculating toxic chemotherapy doses using a formula from the era of the Ford Model T, leading to a system where seven out of eight patients are routinely overdosed. University of Melbourne spin-out PredicTx is dismantling this legacy approach, utilizing advanced AI to analyze existing patient CT scans, deliver precision medicine to the bedside, and return a massive 100x financial rerate to hospital networks.

Join over 45,000+ sophisticated investors

Join Now